Sponsor:
Wake Forest University Health Sciences
Code:
NCT05696782
Conditions
Nonsmall Cell Lung Cancer Stage III
Unresectable Non-Small Cell Lung Carcinoma
Nonsmall Cell Lung Cancer, Stage II
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Durvalumab
the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30)
COPD Assessment Test (CAT)
Modified Medical Research Council (mMRC) dyspnea scale
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2025-04-23.